339 related articles for article (PubMed ID: 35933095)
1. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin
Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P
Bone; 2022 Nov; 164():116511. PubMed ID: 35933095
[TBL] [Abstract][Full Text] [Related]
2. Iron Overload-Induced Osteocyte Apoptosis Stimulates Osteoclast Differentiation Through Increasing Osteocytic RANKL Production In Vitro.
Yang J; Dong D; Luo X; Zhou J; Shang P; Zhang H
Calcif Tissue Int; 2020 Nov; 107(5):499-509. PubMed ID: 32995951
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
[TBL] [Abstract][Full Text] [Related]
4. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement.
Shu R; Bai D; Sheu T; He Y; Yang X; Xue C; He Y; Zhao M; Han X
PLoS One; 2017; 12(1):e0167312. PubMed ID: 28081119
[TBL] [Abstract][Full Text] [Related]
5. MLO-Y4 osteocyte-like cells support osteoclast formation and activation.
Zhao S; Zhang YK; Harris S; Ahuja SS; Bonewald LF
J Bone Miner Res; 2002 Nov; 17(11):2068-79. PubMed ID: 12412815
[TBL] [Abstract][Full Text] [Related]
6. IL-6 Enhances Osteocyte-Mediated Osteoclastogenesis by Promoting JAK2 and RANKL Activity In Vitro.
Wu Q; Zhou X; Huang D; Ji Y; Kang F
Cell Physiol Biochem; 2017; 41(4):1360-1369. PubMed ID: 28278513
[TBL] [Abstract][Full Text] [Related]
7. FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions.
Zhang C; Wei W; Chi M; Wan Y; Li X; Qi M; Zhou Y
J Diabetes Res; 2019; 2019():6757428. PubMed ID: 31886284
[TBL] [Abstract][Full Text] [Related]
8. Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells.
Notsu M; Kanazawa I; Takeno A; Yokomoto-Umakoshi M; Tanaka KI; Yamaguchi T; Sugimoto T
Calcif Tissue Int; 2017 Apr; 100(4):402-411. PubMed ID: 28229177
[TBL] [Abstract][Full Text] [Related]
9. Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells.
Tanaka K; Yamaguchi T; Kanazawa I; Sugimoto T
Biochem Biophys Res Commun; 2015 May; 461(2):193-9. PubMed ID: 25721666
[TBL] [Abstract][Full Text] [Related]
10. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of participation of osteocytes in the formation of osteoclasts under hypoxia].
Zhu J; Tang Y; Wu Q; Ji YC; Kang FW
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Oct; 37(5):463-468. PubMed ID: 31721490
[TBL] [Abstract][Full Text] [Related]
14. Osteocytes produce interferon-β as a negative regulator of osteoclastogenesis.
Hayashida C; Ito J; Nakayachi M; Okayasu M; Ohyama Y; Hakeda Y; Sato T
J Biol Chem; 2014 Apr; 289(16):11545-11555. PubMed ID: 24610813
[TBL] [Abstract][Full Text] [Related]
15. Glutathione, N-acetylcysteine and lipoic acid down-regulate starvation-induced apoptosis, RANKL/OPG ratio and sclerostin in osteocytes: involvement of JNK and ERK1/2 signalling.
Fontani F; Marcucci G; Iantomasi T; Brandi ML; Vincenzini MT
Calcif Tissue Int; 2015 Apr; 96(4):335-46. PubMed ID: 25660312
[TBL] [Abstract][Full Text] [Related]
16. Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes.
Wang Z; Weng Y; Ishihara Y; Odagaki N; Ei Hsu Hlaing E; Izawa T; Okamura H; Kamioka H
PeerJ; 2020; 8():e10244. PubMed ID: 33240612
[TBL] [Abstract][Full Text] [Related]
17. Effect of TNF-
Ohori F; Kitaura H; Marahleh A; Kishikawa A; Ogawa S; Qi J; Shen WR; Noguchi T; Nara Y; Mizoguchi I
J Immunol Res; 2019; 2019():9716758. PubMed ID: 31341915
[TBL] [Abstract][Full Text] [Related]
18. Scl-Ab reverts pro-osteoclastogenic signalling and resorption in estrogen deficient osteocytes.
Allison H; Holdsworth G; McNamara LM
BMC Mol Cell Biol; 2020 Nov; 21(1):78. PubMed ID: 33148174
[TBL] [Abstract][Full Text] [Related]
19. Vibration enhances osteoclastogenesis by inducing RANKL expression via NF-κB signaling in osteocytes.
Sakamoto M; Fukunaga T; Sasaki K; Seiryu M; Yoshizawa M; Takeshita N; Takano-Yamamoto T
Bone; 2019 Jun; 123():56-66. PubMed ID: 30902792
[TBL] [Abstract][Full Text] [Related]
20. Iguratimod suppresses sclerostin and receptor activator of NF-κB ligand production via the extracellular signal-regulated kinase/early growth response protein 1/tumor necrosis factor alpha pathway in osteocytes and ameliorates disuse osteoporosis in mice.
Miura T; Etani Y; Noguchi T; Hirao M; Takami K; Goshima A; Kurihara T; Fukuda Y; Ochiai N; Kanamoto T; Nakata K; Okada S; Ebina K
Bone; 2024 Apr; 181():117026. PubMed ID: 38325651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]